Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Portugal,Germany,Australia,Czech Republic,Spain,Italy,France,Turkey,Austria,United States - Promoter: nct
nct
Update Il y a 5 ans
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
The purpose of this study is to investigate whether lenalidomide would reduce the number of red blood cell transfusions (RBC) needed in anemic (RBC transfusion-dependent) participants with low or intermediate-1 risk MDS without a deletion 5q chromosome abnormality. The study also investigated the safety of lenalidomide use in these participants. Two-thirds of the participants received oral lenalidomide and one-third of the participants received oral placebo.
Country
Australia
,
Austria
,
Belgium
,
Canada
,
Czech Republic
,
France
,
Germany
,
Israel
,
Italy
,
Japan
,
Poland
,
Portugal
,
Spain
,
Turkey
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1